Canaccord Genuity has reduced its price target for Mobileye (MBLY), the Israeli autonomous driving technology company, citing growing competition in the advanced driver-assistance systems (ADAS) market. The brokerage now sees a more challenging landscape for the Intel-backed firm, as rivals including Nvidia and Qualcomm intensify their push into the sector. The revised target reflects concerns over pricing pressure and potential market share erosion.
Mobileye, which supplies vision-based chips and software to major automakers, has long been a dominant player in ADAS. However, analysts point to a surge in alternative solutions from both established semiconductor giants and specialised startups. Canaccord's note, published this week, warns that the competitive dynamics could compress Mobileye's margins and slow its adoption rate among car manufacturers.
The news comes amid a broader reassessment of the autonomous vehicle supply chain. While Mobileye's technology remains widely deployed, investors are increasingly focused on the pace of regulatory approval for self-driving features and the ability of suppliers to maintain pricing power. The stock has fallen roughly 15% over the past three months, underperforming the wider technology sector.
For UK investors, the implications extend beyond a single stock. Many large pension funds and retail portfolios hold exposure to semiconductor and automotive themes through ETFs or actively managed funds. A sustained downturn in ADAS-related equities could weigh on returns for those with significant allocation to the technology or industrial sectors. The FTSE 100, meanwhile, has shown limited direct correlation but remains sensitive to global tech sentiment.
Analysts at other houses have offered mixed views. Some argue that Mobileye's long-term contracts with top automakers provide a buffer, while others echo Canaccord's caution. The divergence highlights the uncertainty surrounding the timeline for mass adoption of autonomous driving. For now, the sector remains highly dependent on both technological breakthroughs and regulatory clarity in key markets such as the UK, EU and US.